Pathophysiology of retinal lymphoma

Ocular Immunology and Inflammation

Volumn 17, Issue 4, 2009, Pages 227-237

  Coupland, Sarah E ^a   Chan, Chi Chao ^b   Smith, Justine ^c  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

^b NATIONAL EYE INSTITUTE   (United States)

^c OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

DLBCL; Intraocular lymphoma; IOL; PCNSL; Retinal lymphoma; Vitreal lymphoma; Vitreoretinal lymphoma

Indexed keywords

BIOLOGICAL MARKER; CD20 ANTIGEN; CD79A ANTIGEN; CHEMOKINE RECEPTOR CCR7; CHEMOKINE RECEPTOR CXCR4 ANTAGONIST; CHEMOKINE RECEPTOR CXCR5; COMMON ACUTE LYMPHOBLASTIC LEUKEMIA ANTIGEN; CXCL13 CHEMOKINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; IMMUNOGLOBULIN KAPPA CHAIN; INTERFERON REGULATORY FACTOR 4; INTERLEUKIN 10; INTERLEUKIN 6; KI 67 ANTIGEN; MACROPHAGE INFLAMMATORY PROTEIN 3ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 3BETA; PROTEIN BCL 2; PROTEIN BCL 6; SECONDARY LYMPHOID TISSUE CHEMOKINE; STROMAL CELL DERIVED FACTOR 1; TRANSCRIPTION FACTOR PAX5;

CHROMOSOME TRANSLOCATION; CLINICAL FEATURE; CYTOKINE PRODUCTION; GENE EXPRESSION PROFILING; GENOTYPE; HUMAN; IMMUNOGLOBULIN HEAVY CHAIN GENE; IMMUNOPHENOTYPING; INTRAOCULAR TUMOR; LARGE CELL LYMPHOMA; LYMPHOCYTE STRUCTURE; MUTATIONAL ANALYSIS; NONHUMAN; PATHOPHYSIOLOGY; PROGNOSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; RETINAL LYMPHOMA; REVIEW; SOMATIC MUTATION;

CHEMOKINES; FUNDUS OCULI; GENOTYPE; HUMANS; IMMUNOPHENOTYPING; INTERLEUKIN-10; LYMPHOMA; LYMPHOMA, B-CELL; LYMPHOMA, LARGE B-CELL, DIFFUSE; PROGNOSIS; RETINAL NEOPLASMS; TRANSLOCATION, GENETIC;

EID: 68849085797     PISSN: 09273948     EISSN: 17445078     Source Type: Journal    
DOI: 10.1080/09273940903168696     Document Type: Review

References (90)

1. Swerdlow SH, Campo E, Harris NL, et al. WHO classification of Tumours of Haematopoietic and Lymphoid Tissues. Edited by Lyon, IARC, 2008.
2. Coupland SE, Damato B. Understanding intraocular lymphomas. Clin Experiment Ophthalmol. 2008:36(6):564-578.
3. Chan CC, Gonzales J. Primary Intraocular Lymphoma. Edited by Singapore, London, Hackensack NJ, World Scientific Publishing Co, 2007
4. Smith JR, Rosenbaum JT. Neurological concomitants of uveitis. Br J Ophthalmol. 2004:88(12):1498-1499.
5. Chan CC, Sauer TC. Ocular imaging in primary retinal lymphoma. Am J Ophthalmol. 2009:147(5):764-765.
6. Coupland SE, Heimann H. [Primary intraocular lymphoma]. Ophthalmologe 2004:101(1):87-98.
7. Coupland SE, Heimann H, Bechrakis NE. Primary intraocular lymphoma:a review of the clinical, histopathological and molecular biological features. Graefes Arch Clin Exp Ophthalmol. 2004:242(11):901-913. (Pubitemid 39562324)
8. Davis JL. Diagnosis of intraocular lymphoma. Ocul Immunol Inflamm. 2004:12(1):7-16
9. Coupland SE, Damato B. Lymphomas involving the eye and the ocular adnexa. Curr Opin Ophthalmol. 2006:17(6):523-531. (Pubitemid 44655585)
10. Levy-Clarke GA, Greenman D, Sieving PC, et al. Ophthalmic manifestations, cytology, immunohistochemistry, and molecular analysis of intraocular metastatic T-cell lymphoma:report of a case and review of the literature. Surv Ophthalmol. 2008:53():285-295. (Pubitemid 351685723)
11. Levy-Clarke GA, Chan CC, Nussenblatt RB. Diagnosis and management of primary intraocular lymphoma. Hematol Oncol Clin North Am. 2005:19(3):739-749. (Pubitemid 41096717)
12. Fardeau C, Lee CP, Merle-Béral H, et al. P. Retinal fluorescein, indocyanine green angiography, and optic coherence tomography in non-Hodgkin primary intraocular lymphoma. Am J Ophthalmol. 2009:147(5):886-894.
13. Feiden W, Milutinovic S. [Primary CNS lymphomas. Morphology and diagnosis]. Pathologe 2002:23(4):284-291.
14. Smith JR, Braziel RM, Paoletti S, et al. Expression of B-cellattracting chemokine 1 (CXCL13) by malignant lymphocytes and vascular endothelium in primary central nervous system lymphoma. Blood 2003:101(3):815-821. (Pubitemid 36139344)
15. Smith JR, Falkenhagen KM, Coupland SE, et al. Malignant B cells from patients with primary central nervous system lymphoma express stromal cell-derived factor-1. Am J Clin Pathol. 2007:127(4):633-641.
16. Jahnke K, Coupland SE, Na IK, et al. Expression of the chemokine receptors CXCR4, CXCR5, and CCR7 in primary central nervous system lymphoma. Blood 2005:106(1):384-385. (Pubitemid 40967218)
17. Brunn A, Montesinos-Rongen M, Strack A, et al. Expression pattern and cellular sources of chemokines in primary central nervous system lymphoma. Acta Neuropathol. 2007:114(3):271-276. (Pubitemid 47226153)
18. Coupland SE, Hummel M, Muller HH, Stein H. Molecular analysis of immunoglobulin genes in primary intraocular lymphoma. Invest Ophthalmol Vis Sci. 2005:46(11):3507-3514. (Pubitemid 44264650)
19. Coupland SE, Hummel M, Stein H, et al. Demonstration of identical clonal derivation in a case of "oculocerebral" lymphoma. Br J Ophthalmol. 2005:89(2):238-239.
20. Cummings TJ, Stenzel TT, Klintworth G, Jaffe GJ. Primary intraocular T-cell-rich large B-cell lymphoma. Arch Pathol LabMed. 2005:129(8):1050-1053. (Pubitemid 41060647)
21. Coupland SE, Anastassiou G, Bornfeld N, et al. Primary intraocular lymphoma of T-cell type:report of a case and review of the literature. Graefes Arch Clin ExpOphthalmol. 2005:243(3):189-197. (Pubitemid 40521090)
22. Goldey SH, Stern GA, Oblon DJ, et al. Immunophenotypic characterization of an unusual T-cell lymphoma presenting as anterior uveitis. A clinicopathologic case report. Arch Ophthalmol. 1989:107(9):1349-1353.
23. Lobo A, Larkin G, Clark BJ, et al. Pseudo-hypopyon as the presenting feature in B-cell and T-cell intraocular lymphoma. Clin Experiment Ophthalmol. 2003:31(2):155-158. (Pubitemid 36553141)
24. Saenz AD, Amador A, Ruiz BM, et al. Cytofluorographic and molecular identification of a CD8-positive, TCR-alpha/betanegative intraocular T cell lymphoma:a case report and review of the literature. J Med Case Reports 2007:1:114. (Pubitemid 351827555)
25. Zaldivar RA, Martin DF, Holden JT, Grossniklaus HE. Primary intraocular lymphoma:clinical, cytologic, and flow cytometric analysis. Ophthalmology 2004:111(9):1762-1767.
26. Coupland SE, Bechrakis NE, Anastassiou G, et al. Evaluation of vitrectomy specimens and chorioretinal biopsies in the diagnosis of primary intraocular lymphoma in patients with Masquerade syndrome. Graefes Arch Clin Exp Ophthalmol. 2003:10(10):860-870. (Pubitemid 37407899)
27. Gonzales JA, Chan CC. Biopsy techniques and yields in diagnosing primary intraocular lymphoma. Int Ophthalmol. 2007:27(4):241-250.
28. Coupland SE, Loddenkemper C, Smith JR, et al. Expression of immunoglobulin transcription factors in primary intraocular lymphoma and primary central nervous system lymphoma. Invest Ophthalmol Vis Sci. 2005:46(11):3957-3964. (Pubitemid 44264593)
29. Chan CC. Molecular pathology of primary intraocular lymphoma. Trans Am Ophthalmol Soc. 2003:101:275-292. (Pubitemid 38209334)
30. Alizadeh AA, Eisen MB, Davis RE, et al. Distinct types of diffuse large cell B-cell lymphoma identified by gene expression profiling. Nature 2000:403(6769):503-511. (Pubitemid 30082188)
31. Monti S, Savage KJ, Kutok JL, et al. Molecular profiling of diffuse large B-cell lymphoma identifies robust subtypes including one characterized by host inflammatory response. Blood 2005:105(5):1851-1861. (Pubitemid 40731764)
32. Staudt LM. Molecular diagnosis of the hematologic cancers. N Engl J Med. 2003:348(18):1777-1785.
33. Davis RE, Brown KD, Siebenlist U, Staudt LM. Constitutive nuclear factor kappaB activity is required for survival of activated B cell-like diffuse large B cell lymphoma cells. J Exp Med. 2001:194(12):1861-1874. (Pubitemid 34028664)
34. Bea S, Colomo L, Lopez-Guillermo A, et al. Clinicopathologic significance and prognostic value of chromosomal imbalances in diffuse large B-cell lymphomas. J Clin Oncol. 2004:22(17):3498-3506. (Pubitemid 41103656)
35. Bea S, Zettl A, Wright G, et al. Diffuse large B-cell lymphoma subgroups have distinct genetic profiles that influence tumor biology and improve gene-expression-based survival prediction. Blood 2005:106(9):3183-3190. (Pubitemid 41565917)
36. Pasqualucci L, Compagno M, Houldsworth J, et al. Inactivation of the PRDM1/BLIMP1 gene in diffuse large B cell lymphoma. J Exp Med. 2006:203(2):311-317. (Pubitemid 43290840)
37. Huang JZ, Sanger WG, Greiner TC, et al. The t(14;18) defines a unique subset of diffuse large B-cell lymphoma with a germinal center B-cell gene expression profile. Blood 2002:99(7):2285-2290. (Pubitemid 34525409)
38. Iqbal J, Sanger WG, Horsman DE, et al. BCL2 translocation de- fines a unique tumor subset within the germinal center B-celllike diffuse large B-cell lymphoma. Am J Pathol. 2004:165(1):159-166. (Pubitemid 38821823)
39. Dybkaer K, Iqbal J, Zhou G, ChanWC. Molecular diagnosis and outcome prediction in diffuse large B-cell lymphoma and other subtypes of lymphoma. Clin. Lymphoma 2004:5(1):19-28. (Pubitemid 39136439)
40. Feuerhake F, Kutok JL, Monti S, et al. NFkappaB activity, function, and target-gene signatures in primary mediastinal large B-cell lymphoma and diffuse large B-cell lymphoma subtypes. Blood 2005:106(4):1392-1399. (Pubitemid 41129606)
41. Rosenwald A, Wright G, Chan WC, et al. The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma. N Eng J Med. 2002:346(25):1937-1947. (Pubitemid 34651353)
42. Shipp MA, Ross KN, Tamayo P, et al. Diffuse large B-cell lymphoma outcome predicted by gene-expression profiling and supervised machine learning. Nat Med. 2002:8(1):68-74. (Pubitemid 34101731)
43. Wright G, Tan B, Rosenwald A, et al. A gene expression-based method to diagnose clinically distinct subgroups of diffuse large B cell lymphoma. Proc Natl Acad Sci U S A. 2003:100(17):9991-9996. (Pubitemid 37087056)
44. Hans CP, Weisenburger DD, Greiner TC, et al. Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray. Blood 2004:103(1):275-282.
45. de Jong D, Rosenwald A, Chhanabhai M, et al. Immunohistochemical prognostic markers in diffuse large B-cell lymphoma: validation of tissue microarray as a prerequisite for broad clinical applications-a study from the Lunenburg Lymphoma Biomarker Consortium. J Clin Oncol. 2007:25(7):805-812. (Pubitemid 350002880)
46. Wallace DJ, Shen D, Reed GF, et al. Detection of the bcl-2 t(14;18) translocation and proto-oncogene expression in primary intraocular lymphoma. Invest Ophthalmol Vis Sci .2006:47(7):2750-2756.
47. Weiss LM, Warnke RA, Sklar J, Cleary ML. Molecular analysis of the t(14;18) chromosomal translocation in malignant lymphomas. N Engl J Med. 1987:317(19):1185-1189. (Pubitemid 17150330)
48. Jacobson JO, Wilkes BM, Kwaiatkowski DJ, et al. bcl-2 rearrangements in de novo diffuse large cell lymphoma. Association with distinctive clinical features. Cancer 1993:72(1):231-236.
49. Malumbres R, Davis J, Ruiz P, Lossos IS. Somatically mutated immunoglobulin IGHV@ genes without intraclonal heterogeneity indicate a postgerminal centre origin of primary intraocular diffuse large B-cell lymphomas. Br J Haematol. 2007:138(6):749-755. (Pubitemid 47313226)
50. Montesinos-Rongen M, Kuppers R, Schluter D, et al. Primary central nervous system lymphomas are derived from germinalcenter B cells and show a preferential usage of the V4-34 gene segment. Am J Pathol. 1999:155(6):2077- 2086.
51. Pels H, Montesinos-Rongen M, Schaller C, et al. VH gene analysis of primary CNS lymphomas. J Neurol Sci. 2005:228(2):143-147. (Pubitemid 40202959)
52. Thompsett A, Ellison D, Stevenson F, Zhu D. V(H) gene sequences from primary central nervous system lymphomas indicate derivation from highly mutated germinal center B cells with ongoing mutational activity. Blood 1999:94(5):1738-1746. (Pubitemid 29411324)
53. Smith JR, Henderson WW, Rosenbaum JT, et al. Cultured human endothelial cells expressing HIV-1 Vpu and Tat support the expansion of malignant B cells from primary central nervous system lymphoma. Br J Ophthalmol. 2008:92(2):297-299.
54. Chan CC, Fischette M, Shen D, et al. Murine model of primary intraocular lymphoma. Invest Ophthalmol Vis Sci. 2005:46(2):415-419. (Pubitemid 40270316)
55. Li Z, Mahesh SP, Shen de F, et al. Eradication of tumor colonization and invasion by a B cell-specific immunotoxin in a murine model for human primary intraocular lymphoma. Cancer Res. 2006:66(21):10586-10593. (Pubitemid 44799782)
56. Touitou V, Daussy C, Bodaghi B, et al. Impaired th1/tc1 cytokine production of tumor-infiltrating lymphocytes in amodel of primary intraocular B-cell lymphoma. Invest Ophthalmol Vis Sci. 2007:48(7):3223-3229. (Pubitemid 351261167)
57. Hochman J, Assaf N, Deckert-Schluter M, et al. Entry routes of malignant lymphoma into the brain and eyes in a mousemodel. Cancer Res. 2001:61(13):5242-5247. (Pubitemid 32681559)
58. Mineo JF, Scheffer A, Karkoutly C, et al. Using human CD20- transfected murine lymphomatous B cells to evaluate the efficacy of intravitreal and intracerebral rituximab injections in mice. Invest Ophthalmol Vis Sci. 2008:49(11):4738-4745.
59. Kadoch C, Treseler P, Rubenstein JL. Molecular pathogenesis of primary central nervous system lymphoma. Neurosurg Focus 2006:21(5):E1.
60. Rubenstein JL, Fridlyand J, Shen A, et al. Gene expression and angiotropism in primary CNS lymphoma. Blood 2006:107(9):3716-3723.
61. Courts C, Montesinos-Rongen M, Martin-Subero JI, et al. Transcriptional profiling of the nuclear factor-kappaB pathway identifies a subgroup of primary lymphoma of the central nervous system with low BCL10 expression. J Neuropathol Exp Neurol. 2007:66(3):230-237. (Pubitemid 46673278)
62. Camilleri-Broet S, Criniere E, Broet P, et al. A uniform activated B-cell-like immunophenotypemight explain the poor prognosis of primary central nervous system lymphomas:analysis of 83 cases. Blood 2006:107(1):190-196. (Pubitemid 43053543)
63. Lin CH, KuoKT, Chuang SS, et al. Comparison of the expression and prognostic significance of differentiation markers between diffuse large B-cell lymphoma of central nervous system origin and peripheral nodal origin. Clin Cancer Res. 2006;12(4):1152-1156
64. Montesinos-Rongen M, Brunn A, Bentink S, et al. Gene expression profiling suggests primary central nervous system lymphomas to be derived from a late germinal center B cell. Leukemia 2008:22(2):400-405. (Pubitemid 351250546)
65. Blay JY, Favrot M, Rossi JF, Wijdenes J. Role of interleukin-6 in paraneoplastic thrombocytosis. Blood 1993:82(7):2261-2262.
66. Bost KL, Bieligk SC, Jaffe BM. Lymphokine mRNA expression by transplantable murine B lymphocytic malignancies. Tumorderived IL-10 as a possible mechanism for modulating the antitumor response. J Immunol. 1995:154(2):718-729.
67. Chan CC, Whitcup SM, Solomon D, Nussenblatt RB. Interleukin-10 in the vitreous of patients with primary intraocular lymphoma. Am J Ophthalmol. 1995:120(5):671-673.
68. Cassoux N, Merle-Beral H, Lehoang P, et al. Interleukin-10 and intraocular-central nervous system lymphoma. Ophthalmology 2001:108(3):426-427.
69. Merle-Beral H, Davi F, Cassoux N, et al. Biological diagnosis of primary intraocular lymphoma. Br J Haematol. 2004:124(4):469-473. (Pubitemid 38230591)
70. Whitcup SM, Stark-Vancs V, Wittes RE, et al. Association of interleukin 10 in the vitreous and cerebrospinal fluid and primary central nervous system lymphoma. Arch Ophthalmol. 1997:115(9):1157-1160.
71. Wolf LA, Reed GF, Buggage RR, et al. Vitreous cytokine levels. Ophthalmology 2003:110(8):1671-1672.
72. Rousset F, Garcia E, Defrance T, et al. Interleukin 10 is a potent growth and differentiation factor for activated human B lymphocytes. Proc Natl Acad Sci U S A. 1992:89(5):1890-1893.
73. Beatty PR, Krams SM, Martinez OM. Involvement of IL-10 in the autonomous growth of EBV-transformed B cell lines. J Immunol. 1997:158(9):4045-4051.
74. Moore KW, de Waal Malefyt R, Coffman RL, O'Garra A. Interleukin-10 and the interleukin-10 receptor. Annu Rev Immunol. 2001:19:683-765.
75. Fiorentino DF, Bond MW, Mosmann TR. Two types of mouse T helper cell. IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones. J Exp Med. 1989:170(6):2081-2095.
76. Levy Y, Brouet JC. Interleukin-10 prevents spontaneous death of germinal center B cells by induction of the bcl-2 protein. J Clin Invest. 1994:93(1):424-428. (Pubitemid 24030864)
77. Benjamin D, Knobloch TJ, Dayton MA. Human B-cell interleukin-10:B-cell lines derived from patients with acquired immunodeficiency syndrome and Burkitt's lymphoma constitutively secrete large quantities of interleukin-10. Blood 1992:80(5):1289-1298.
78. Emilie D, Touitou R, Raphael M, et al. In vivo production of interleukin-10 by malignant cells in AIDS lymphomas. Eur J Immunol. 1992:22(11):2937-2942.
79. Herbst H, Foss HD, Samol J, et al. Frequent expression of interleukin-10 by Epstein-Barr virus-harboring tumor cells of Hodgkin's disease. Blood 1996:87(7):2918-2929. (Pubitemid 26102243)
80. Cassoux N, Giron A, Bodaghi B, et al. IL-10 measurement in aqueous humor for screening patients with suspicion of primary intraocular lymphoma. Invest Ophthalmol Vis Sci. 2007:48(7):3253-3259. (Pubitemid 351261171)
81. Sou R, Ohguro N, Maeda T, et al. Treatment of primary intraocular lymphoma with intravitrealmethotrexate. Jpn J Ophthalmol. 2008:52(3):167-174.
82. Sen HN, Chan CC, Byrnes G, et al. Intravitreal methotrexate resistance in a patient with primary intraocular lymphoma. Ocul Immunol Inflamm. 2008:16(1):29-33.
83. Nacinovic-Duletic A, Stifter S, Dvornik S, et al. Correlation of serum IL-6, IL-8 and IL-10 levels with clinicopathological features and prognosis in patients with diffuse large B-cell lymphoma. Int J Lab Hematol. 2008:30(3):230-239. (Pubitemid 351695395)
84. Wang SS, Cozen W, Cerhan JR, et al. Immune mechanisms in non-Hodgkin lymphoma:joint effects of the TNF G308A and IL10 T3575A polymorphisms with non-Hodgkin lymphoma risk factors. Cancer Res. 2007:67(10):5042-5054. (Pubitemid 46910215)
85. Kube D, Hua TD, von Bonin F, et al. Effect of interleukin-10 gene polymorphisms on clinical outcome of patients with aggressive non-Hodgkin's lymphoma:an exploratory study. Clin Cancer Res. 2008:14(12):3777-3784.
86. Park YH, Sohn SK, Kim JG, et al. Interaction between BCL2 and interleukin-10 gene polymorphisms alter outcomes of diffuse large B-cell lymphoma following rituximab plus CHOP chemotherapy. Clin Cancer Res. 2009:15(6):2107-2115.
87. Hochberg FH, Miller DC. Primary central nervous system lymphoma. J Neurosurg. 1988:68(6):835-853.
88. Cyster JG. Chemokines and cell migration in secondary lymphoid organs. Science 1999:286(5447):2098-2102.
89. Casamayor-Palleja M, Mondiere P, Amara A, et al. Expression of macrophage inflammatory protein-3alpha, stromal cell-derived factor-1, and B-cell-attracting chemokine-1 identifies the tonsil crypt as an attractive site for B cells. Blood 2001:97(12):3992-3994.
90. Chan CC, Shen D, Hackett JJ, et al. Expression of chemokine receptors, CXCR4 and CXCR5, and chemokines, BLC and SDF- 1, in the eyes of patients with primary intraocular lymphoma. Ophthalmology 2003:110(2):421-426. (Pubitemid 36184350)